Chemical interfering with hormone signalling (agonist, antagonist, biosynthesis/clearance modulator). BPA, phthalates, PCBs, PFAS. Non-monotonic dose–response and developmental-window sensitivity complicate risk assessment.
Chemical interfering with hormone signalling (agonist, antagonist, biosynthesis/clearance modulator). BPA, phthalates, PCBs, PFAS. Non-monotonic dose–response and developmental-window sensitivity complicate risk assessment.